Bacterial contamination and antimicrobial susceptibility patterns of intensive care units medical equipment and inanimate surfaces at Ayder Comprehensive Specialized Hospital, Mekelle, Northern Ethiopia.
Anti-Bacterial Agents
/ pharmacology
Ciprofloxacin
/ pharmacology
Cross-Sectional Studies
Drug Resistance, Multiple, Bacterial
Equipment Contamination
/ statistics & numerical data
Escherichia coli
/ drug effects
Ethiopia
Fomites
/ microbiology
Gentamicins
/ pharmacology
Hospitals, Special
Humans
Intensive Care Units
Microbial Sensitivity Tests
Staphylococcus aureus
/ drug effects
Tetracycline
/ pharmacology
Antimicrobial susceptibility pattern
Bacterial contamination
Ethiopia
Inanimate surfaces
Medical equipment
Journal
BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768
Informations de publication
Date de publication:
23 Sep 2019
23 Sep 2019
Historique:
received:
28
06
2019
accepted:
18
09
2019
entrez:
25
9
2019
pubmed:
25
9
2019
medline:
6
2
2020
Statut:
epublish
Résumé
To determine bacterial contaminants and their antimicrobial susceptibility patterns from medical equipment and inanimate surfaces. Of 130 swabs, 115 (88.5%) swabs were culture positive, of which contaminated medical equipment and inanimate surfaces account 70 (83.3%) and 45 (97.8%), respectively. All the swabs collected from sphygmomanometer, bedside table, computer and computer standing tables were 100% contaminated with bacteria. From the culture-positive swabs, a total of 171 bacterial isolates were identified, out of which 117 (68.4%) and 54 (31.6%) isolates were gram-positive and gram-negative, respectively. Most isolates (82%) were resistant to ampicillin and 13%, 8.6%, and 14% was observed in ciprofloxacin, gentamicin, and tetracycline respectively. Multi-drug resistant was observed in Escherichia coli (72.7%) and Staphylococcus aureus (58.7%).
Identifiants
pubmed: 31547851
doi: 10.1186/s13104-019-4658-5
pii: 10.1186/s13104-019-4658-5
pmc: PMC6757422
doi:
Substances chimiques
Anti-Bacterial Agents
0
Gentamicins
0
Ciprofloxacin
5E8K9I0O4U
Tetracycline
F8VB5M810T
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
621Références
J Clin Monit Comput. 2004 Feb;18(1):7-12
pubmed: 15139578
Crit Care. 2006;10(2):R66
pubmed: 16626503
Infect Control Hosp Epidemiol. 2006 Sep;27(9):940-3
pubmed: 16941320
J Hosp Infect. 2008 Apr;68(4):285-92
pubmed: 18329137
Acta Paediatr. 2008 Sep;97(9):1253-5
pubmed: 18554272
Anaesthesia. 2009 Jun;64(6):620-4
pubmed: 19453315
BMC Infect Dis. 2009 Jul 25;9:115
pubmed: 19630992
Ann Surg Innov Res. 2009 Jul 30;3:8
pubmed: 19642994
JAMA. 2009 Dec 2;302(21):2323-9
pubmed: 19952319
J Infect Dev Ctries. 2010 Aug 04;4(7):436-41
pubmed: 20818091
Clin Microbiol Infect. 2011 Aug;17(8):1201-8
pubmed: 21054665
Am J Infect Control. 2011 Sep;39(7):602-4
pubmed: 21496956
Eur Rev Med Pharmacol Sci. 2012 Aug;16(8):1039-44
pubmed: 22913154
Glob J Health Sci. 2012 Nov 11;5(1):143-9
pubmed: 23283046
Biomed Res Int. 2013;2013:429780
pubmed: 24286078
Ann Clin Microbiol Antimicrob. 2013 Dec 13;12:39
pubmed: 24330702
J Infect Dev Ctries. 2014 Jan 15;8(1):86-93
pubmed: 24423717
Indian J Med Microbiol. 2014 Apr-Jun;32(2):201-2
pubmed: 24713919
J Trop Med. 2014;2014:545160
pubmed: 25309601